SUSQUEHANNA INTERNATIONAL GROUP, LLP - CHECKPOINT THERAPEUTICS INC ownership

CHECKPOINT THERAPEUTICS INC's ticker is and the CUSIP is 162828206. A total of 35 filers reported holding CHECKPOINT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$128,251
-32.7%
75,442
-2.3%
0.00%
Q2 2023$190,647
-6.0%
77,185
-14.4%
0.00%
Q1 2023$202,826
+65.2%
90,145
+275.2%
0.00%
Q4 2022$122,78824,0290.00%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 54,983$280,9631.24%
TWINBEECH CAPITAL LP 113,152$14,275,2560.27%
Telemetry Investments, L.L.C. 10,000$510.08%
ARMISTICE CAPITAL, LLC 691,895$3,535,5830.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 12,564$64,2020.04%
EMFO, LLC 7,795$39,8320.04%
Apollon Wealth Management, LLC 26,358$134,6890.01%
PARK AVENUE SECURITIES LLC 46,545$238,0000.00%
B. Riley Wealth Advisors, Inc. 19,150$97,8570.00%
Tower Research Capital LLC (TRC) 9,548$490.00%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders